Brief report: Two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism

Journal of Autism and Developmental Disorders

Volumn 29, Issue 1, 1999, Pages 87-91

  Dartnall, Nancy A ^a,e   Holmes, Janice P ^b   Morgan, Susan Naylor ^c   McDougle, Christopher J ^d  

^a Connecticut Dept Mental Retard S ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d INDIANA UNIVERSITY   (United States)

^e Dept Mental Retard S Ctrl Reg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; LAMOTRIGINE; RISPERIDONE; VALPROIC ACID;

ADULT; AGGRESSION; ARTICLE; AUTISM; AUTOMUTILATION; BEHAVIOR; BEHAVIOR DISORDER; CASE REPORT; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; SEIZURE;

ADULT; AUTISTIC DISORDER; COMPULSIVE BEHAVIOR; DOPAMINE ANTAGONISTS; FEMALE; GYNECOMASTIA; HUMANS; MALE; MENTAL RETARDATION; RISPERIDONE; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0033016724     PISSN: 01623257     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025926817928     Document Type: Article

References (16)

1. Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G. W., Labelle, A., Beauclaire, L., & Amott, W. (1993). A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia. Journal of Clinical Psychopharmacology, 13, 5-40.
2. Cook, E. H., Jr., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 739-745.
3. Feeney, D. J., & Klykylo, W. (1996). Risperidone and tardive dyskinesia. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1421-1422.
4. Gordon, C. T., State, R. C., Nelson, J. E., Hamburger, S., & Rapoport, J. L. (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Archives of General Psychiatry, 50, 441-447.
5. Grant, S., & Fitton, A. (1994). Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Drugs, 48, 253-273.
6. Hardan, A., Johnson, K., Johnson, C., & Hrecznyj, B. (1996). Case study: Risperidone treatment of children and adolescents with developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1551-1556.
7. Horrigan, J. P., & Bamhill, L. J. (1997). Risperidone and explosive aggressive autism. Journal of Autism and Developmental Disorders. 27, 313-323.
8. Kumra, S., Herion, D., Jacobsen, L. K., Briguglia, C., & Grothe, D. (1997). Case study: Risperidone-induced hepatotoxicity in pediatric patients. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 701-705.
9. Leysen, J. E., Janssen, P. M. F., Megens, A. A. H. P., & Schotte, A. (1994). Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. Journal of Clinical Psychiatry, 55 (5, Suppl.), 5-12.
10. McDougle, C. J., Brodkin, E. S., Yeung, P. P., Naylor, S. T., Cohen, D. J., & Price, L. H. (1995). Risperidone in adults with autism or pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology, 34, 273-282.
11. McDougle, C. J., Holmes, J. P., Bronson, M. R., Anderson, G. M., Volkmar, F. R., Price, L. H., & Cohen, D. J. (1997). Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 685-693.
12. McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-Wind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001-1008.
13. Purdon, S. E., Lit, W., Labelle, A., & Jones, B. D. (1994). Risperidone in the treatment of pervasive developmental disorder. Canadian Journal of Psychiany, 39, 400-405.
14. Simon, E. W., Blubaugh, K. M., & Pippidis, M. (1996). Substituting traditional antipsychotics with risperidone for individuals with mental retardation. Mental Retardation, 34, 359-366.
15. Touchette, P. E., MacDonald, R. F., & Langer, S. N. (1985). A scatterplot for identifying stimulus control of problem behavior. Journal of Applied Behavior Analysis, 18, 343-351.
16. Vanden Borre, R., Butriens, M., Thiry, P., Geurjens, J., Sieben, G., & Heylen, S. (1993). Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind, cross-over study. Acta Psychiatrica Scandinavia, 87, 167-171.